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Lymphangiogenesis in myocardial remodelling after infarction
Aims: The lymphatic system is involved in ﬂuid
homeostasis of the cardiac interstitium, but lymph-
angiogenesis in myocardial remodelling has not pre-
viously been examined histopathologically. The aim
was to investigate by D2-40 immunohistochemistry
the sequential changes in lymphatic distribution in the
process of myocardial remodelling after myocardial
infarction (MI).
Methods and results: Myocardial tissues in various
phases of healing after MI were obtained from 40
autopsied hearts. D2-40+ lymphatic vessel density (LD)
and CD34+ blood vessel density (BD) in the lesion were
determined. BD decreased with advance of myocardial
necrosis, subsequently increased at the early stage of
granulation and thereafter decreased with the progres-
sion of scar formation. In contrast, lymphatic vessels
were not detected in lesions with coagulation necrosis,
and newly formed lymphatics ﬁrst appeared in the early
stages of granulation. A subsequent increase in LD was
demonstrated in the late stages of granulation, and
lymphatics remained up to the scar phase. Vascular
endothelial growth factor-C was consistently expressed
in viable cardiomyocytes around the lesion in all of
these stages.
Conclusion: In myocardial remodelling after MI, lym-
phangiogenesis lags behind blood vessel angiogenesis;
newly formed lymphatics may be involved mainly in
the maturation of ﬁbrosis and scar formation through
the drainage of excessive proteins and ﬂuid.
Keywords: blood vessel, lymphangiogenesis, lymphatic vessel, myocardial infarction, myocardial remodelling,
vascular endothelial growth factor-C
Abbreviations: AMI, acute myocardial infarction; BD, blood vessel density; H&E, haematoxylin and eosin;
LD, lymphatic density; LYVE-1, lymphatic endothelial hyaluronan receptor-1; MI, myocardial infarction;
OMI, old myocardial infarction; SMA, smooth muscle actin; VEGF, vascular endothelial growth factor
Introduction
Myocardial ﬂuid homeostasis is modulated by the
balance between ﬂuid ﬁltration into the myocardial
interstitium from blood capillaries and its removal
from the interstitium via the lymphatic system.
1
Impairment of cardiac lymphatic ﬂow due to several
pathological states, such as ventricular ﬁbrillation,
increased superior vena caval pressure, pulmonary
artery hypertension and myocardial ischaemia, results
in excess ﬂuid accumulation within the myocardial
interstitium,
1 which often leads to interstitial ﬁbro-
sis, pericardial effusion and subsequent myocardial
dysfunction.
2,3 In the mammalian heart, cardiac
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plexus to the subepicardial lymphatic plexus through
intramyocardial lymphatic channels.
3 These cardiac
lymphatic networks in human and animals have
repeatedly been investigated in detail by observations
using dye-injection techniques, electron microscopy
and lymphangiography.
3–5 However, these tech-
niques are inappropriate for histopathological obser-
vation of the lymphatic system in formalin-ﬁxed
parafﬁn-embedded tissues obtained from myocardial
tissues.
In the human heart, myocardial remodelling after
myocardial infarction (MI) results in scar formation
through several sequential stages of myocardial necro-
sis, granulation and ﬁbrosis.
6 In the process of myo-
cardial remodelling, the viable cardiomyocytes around
the lesion express cytoprotective proteins and cytokines
which facilitate the healing of the affected lesion.
7,8 In
addition, prolyl 4-hydroxylase expressed in the cardio-
myocytes around the lesion as well as ﬁbronectin and
adiponectin expressed in the affected area effectively
contribute to interstitial remodelling.
9 Myocardial
remodelling is, thus, dependent on various contribu-
tors, and vascular endothelial growth factor (VEGF) is
critical for angiogenesis in the healing area.
10 VEGF is
promptly expressed in the surviving cardiomyocytes
around the infracted lesion after the onset of MI
7 and
angiogenesis in the lesion begins at 4–5 h and contin-
ues up to day 90.
11 The process of angiogenesis in the
infarcted area has been investigated sporadically,
12,13
but lymphangiogenesis in the healing process of MI has
not previously been examined. This is probably due to
the lack of a reliable marker that can distinguish the
lymphatic endothelium from the blood capillary endo-
thelium.
In recent years, lymphatic endothelial cell-speciﬁc
proteins have been identiﬁed, including VEGF recep-
tor-3, lymphatic endothelial hyaluronan receptor-1
(LYVE-1), podoplanin, prox-1, D6 and D2-40.
14,15 We
have also examined lymphatic distribution in various
human tissues using polyclonal LYVE-1 rabbit anti-
body and D2-40 antibody.
14,16 In the heart, a recent
study has reported lymphatic morphology and density
in transplanted cardiac tissues by immunohistochem-
istry using anti-ﬂt-4 (VEGF receptor-3) antibody,
17 but
did not include lymphangiogenesis in MI lesions. In
this study, we investigated ﬂuctuation of lymphatic
distribution in the entire process of myocardial
remodelling after the onset of MI by immunohisto-
chemistry using D2-40 antibody, which was also
compared with blood vessel distribution as well as
VEGF-C expression in the cardiomyocytes around the
foci.
Materials and methods
materials
Myocardial tissue was obtained from 40 autopsied
patients with acute MI (AMI) and ⁄ or old MI (OMI). As
normal controls, an additional ﬁve cases with no
cardiac lesion were used. All cases were autopsied
within 4 h postmortem. The MI cases included nine
cases of AMI, 15 of OMI and 16 with both AMI and
OMI. All MI lesions were recognized in the left
ventricular walls. The mean age of the 40 patients
with MI was 70.2 ± 9.5 years (range 44–92 years)
and 28 were male and 12 female. The ﬁve control cases
with no cardiac lesion were aged 58–79 years (mean
66.5 ± 8.5 years) consisting of three men and two
women.
tissue preparation and
immunohistochemistry
The 10 normal myocardial tissues were dissected from
the left ventricle of ﬁve control cases. The lesions in
each case of MI were also dissected in the same manner
and there were 88 myocardial tissue blocks with MI.
All myocardial tissues were ﬁxed in 10% neutral
buffered formalin and embedded in parafﬁn. Thin
sections were treated with haematoxylin and eosin
(H&E) and Azan–Mallory staining.
Additional subserial sections from all the above
parafﬁn blocks were used for immunohistochemistry.
The antibodies used were D2-40 (Signet Laboratory
Inc., Dedham, MA, USA), anti-CD34 (DakoCytomation,
Carpinteria, CA, USA), anti-a-smooth muscle actin
(SMA) (DakoCytomation), anti-CD68 (DakoCytoma-
tion) and anti-VEGF-C (Zymed Laboratories Inc., South
San Francisco, CA, USA). Immunohistochemistry was
performed using the Envision+ kit (DakoCytomation)
according to the manufacturer’s instructions, except
for VEGF-C immunohistochemistry, which was per-
formed with the CSA II kit (DakoCytomation). Sections
were visualized by treating the slides with diamino-
benzidine-tetrahydrochloride. To verify antibody speci-
ﬁcity, sections from each parafﬁn block were used
as negative controls by omitting the primary anti-
body and replacing it with normal mouse or rabbit
immunoglobulin.
staging of the lesions
After observation of sections treated with H&E and
Azan–Mallory as well SMA and CD68 immunohisto-
chemistry, each MI lesion was classiﬁed into one of the
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during the healing of MI, as proposed by Lodge-Patch:
6
Stage I, the earliest changes where stretching and
waviness of myocardial ﬁbres are observed and these
myocytes have eosinophilic cytoplasm and pyknosis;
Stage II, coagulation necrosis of cardiomyocytes with
haemorrhage or neutrophil inﬁltration, but without
CD68+ macrophages; Stage III, coagulation necrosis of
cardiomyocytes with inﬁltration of CD68+ macroph-
ages in addition to neutrophils; Stage IV, the early
stage of granulation in which fragmented myocytes
with coagulation necrosis, many CD68+ macrophages,
a few neutrophils and ﬁbroblasts are found; Stage V,
mature granulation tissue with CD68+ macrophages
and ﬁbroblasts, but without necrotic myocytes or
neutrophils; Stage VI, the stage of ﬁbrosis with abun-
dant myoﬁbroblasts positive for SMA, in which the
interstitium is weakly stained blue by Azan–Mallory
throughout the lesion; and Stage VII, the lesion is
replaced with scar tissue with a decrease of myoﬁbro-
blasts and uniformly stained blue by Azan–Mallory.
Of the 88 myocardial lesions, the number of cases in
each stage was nine in Stage I, 18 in Stage II, 13 in
Stage III, 11 in Stage IV, six in Stage V, 14 in Stage VI
and 17 in Stage VII.
statistical analyses
In the normal cases, the sections immunostained with
D2-40 antibody were observed by light microscopy at
·200 magniﬁcation. Only vessels with a lumen or
consisting of more than a single endothelial cell positive
for D2-40 were considered as lymphatic vessels. The
number of D2-40+ lymphatics in the myocardial
interstitium was counted at random in 20 ﬁelds and
the total number of lymphatics in 20 ﬁelds was deﬁned
as lymphatic vessel density (LD) in each section. The
sections immunopositive for CD34 antibody were
observed in the same way as in the count of LD cases.
The total number of CD34+ vessels in 20 ﬁelds was
counted and the number [(the number of CD34+
vessels) ) (the number of D2-40+ vessels)] was deﬁned
as blood vessel density (BD) in each section, because
CD34+ vessels may include both lymphatic and blood
vessels.
In MI cases, sections immunopositive for D2-40
antibody were observed in the same way as normal
cases and the total number of D2-40+ lymphatics in 20
ﬁelds of MI lesions was regarded as the LD in each
lesion. The BD in each lesion was also determined by
the same methods as in normal cases.
The average value of LD in each categorized stage
was statistically compared with those of normal cases
and the other stages by Student’s t-test using the
StatView program (SAS Inc., Cary, NC, USA). The
average value of BD in each categorized stage was also
treated statistically. Differences at P < 0.05 were con-
sidered to be statistically signiﬁcant.
Results
distribution of lymphatic and blood vessels
and vegf-c expression in the left ventricle
of normal heart
In normal hearts, D2-40+ lymphatics were frequently
observed in the interstitium of the subepicardium
(Figure 1a). The interstitium around arteries and veins
distributing in the subepicardial adipose tissue also had
abundant lymphatics. In the normal myocardium,
small lymphatics (lymphatic capillaries) were sporadi-
cally scattered among cardiomyocytes (Figure 1b). In
the interstitium around arteries and veins running in
the myocardium, relatively abundant lymphatics were
distributed, and they had larger lumens than lymphatic
capillaries existing among myocytes (Figure 1c). In the
subendocardium, there were abundant lymphatics.
These distribution patterns of lymphatics in the ven-
tricular wall were commonly recognized in the ante-
rior, lateral and posterior walls.
On the other hand, blood vessels were more numer-
ous in the normal myocardium compared with the
lymphatics. In the subepicardial region, coronary
arteries and veins were found, and a few capillaries
positive for CD34 were seen in the interstitium of
subepicardial adipose tissue. In the ventricular myo-
cardium, blood capillaries were numerous among
cardiomyocytes (Figure 1d).
distribution of lymphatic and blood vessels
and vegf-c expression in the myocardium
affected by mi
Stage I
The interstitium in this lesion was oedematous
and included a few D2-40+ lymphatic capillaries
(Figure 2a), but the number of lymphatics seemed to
be decreased compared with that in the normal
myocardium. VEGF-C was weakly expressed in the
viable cardiomyocytes around the lesion as well as
being strongly expressed in the affected cardiomyocytes
(Figure 2b).
Capillaries positive for CD34 in this lesion were
abundant, but there was a mild decrease in their density
compared with that in the normal myocardium. Arte-
riolesandvenuleswereintact,aswerearteriesandveins.
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D2-40+ lymphatic vessels were not seen in the
interstitium of the lesion. In addition, the number of
capillaries positive for CD34 also decreased compared
with Stage I. Endothelial cells of arterioles and venules
were barely positive for CD34, and those of arteries and
veins were relatively intact. VEGF-C expression was
widely demonstrated in the cardiomyocytes around the
foci, but not in coagulative myocytes.
Stage III
In the interstitium, lymphatic vessels were not seen,
nor were blood capillaries; arterioles and venules were
rarely detected. Endothelial cells of arteries and veins
were barely positive for CD34. VEGF-C was expressed in
viable cardiomyocytes around the lesions.
Stage IV
A few D2-40+ lymphatics were found in the peripheral
region of the affected area (Figure 2c). On the other
hand, capillaries positive for CD34 were abundant
throughout the affected lesion and a small number of
muscular blood vessels showing immunopositivity for
SMA were also observed in the peripheral region.
VEGF-C was expressed in the cardiomyocytes around
the lesion.
Stage V
This stage exhibited mature granulation tissue in
which CD68+ macrophages and ﬁbroblasts were rela-
tively abundant with a few lymphocytes. The intersti-
tium of this lesion was barely stained light blue with
Azan–Mallory. Lymphatics were mainly distributed in
a
200 µm
c
b
d
200 µm
200 µm 200 µm
Figure 1. D2-40 (a–c) and CD34 (d) immunohistochemistry in the normal heart. a, D2-40+ lymphatics are abundant in the subepicardium
of the normal heart. Blood vessels indicated by arrows are immunonegative for D2-40. b, Lymphatic capillaries are scattered among
cardiomyocytes. c, The lumens of lymphatics adjacent to blood vessels are dilated. d, CD34+ blood capillaries are numerous among
cardiomyocytes.
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and exhibited a dilated structure. In the central area of
granulation tissue, lymphatics were scarce and capil-
lary in nature. On the other hand, CD34+ vessels were
almost uniformly distributed throughout the lesion and
included many muscular blood vessels immunopositive
for SMA in addition to blood capillaries. VEGF-C
expression was observed in the cardiomyocytes around
the lesion.
Stage VI
In these lesions, dilated lymphatics were observed in
the peripheral region (Figure 3a). Lymphatic capillaries
were also scattered in the lesion and tended to be
distributed in the peripheral region.
The number of blood vessels in ﬁbrous lesions
decreased compared with Stage V. Most blood vessels
observed in this lesion had muscular walls immuno-
positive for SMA, and blood capillaries were rare.
Cardiomyocytes around the lesion were immunoposi-
tive for VEGF-C.
Stage VII
In a scar lesion, cell components were scarce and the
whole area was uniformly stained blue with Azan–
Mallory. Lymphatics were sporadically recognized in
a
200 µm
c
b
d
200 µm
200 µm 200 µm
Figure 2. Immunohistochemistry in Stages I (a,b), IV (c) and V (d). a, A D2-40+ lymphatic vessel is recognized in the interstitium of the lesion
with wavy myocardial ﬁbres (Stage I). b, The upper half of the ﬁgure shows wavy myocardial ﬁbres which are strongly positive for vascular
endothelial growth factor-C (VEGF-C). Cardiomyocytes around the lesion (the lower half of the ﬁgure) are also weakly immunopositive for
VEGF-C. c, In Stage IV, showing the early change of granulation, a small D2-40+ lymphatic vessel (arrow) is shown in the vicinity of the viable
cardiomyocytes (the left upper area of the ﬁgure). d, In Stage V, showing the mature granulation phase with inﬁltration of macrophages and
lymphocytes, D2-40+ lymphatics (arrows) are scattered. A lymphatic vessel in the centre of the ﬁgure contains lymphocytes in the lumen.
Arrowheads indicate muscular blood vessels.
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tissue, lymphatics were scarce, as were CD34+ capil-
laries. The number of muscular blood vessels in scar
tissue decreased compared with Stage VI (Figure 3c).
However, VEGF-C was expressed in the cardiomyocytes
around the lesion, as in the other stages (Figure 3d).
fluctuation of ld and bd in the healing
process of mi lesions
LD in the normal heart and the seven categorized
lesions is indicated in Figure 4a. LD in Stage I was
signiﬁcantly smaller than that in the normal myocar-
dium. In Stages II and III, lymphatic vessels were never
seen in the lesions, but a few lymphatics were observed
in Stage IV. However, LD in Stage IV was signiﬁcantly
less than that in the normal myocardium and Stage I.
In Stages V, VI and VII, LD increased signiﬁcantly
compared with Stage IV, but there was no statistical
difference in LD between Stages V, VI and VII.
BD in the normal heart and the seven categorized
lesions is indicated in Figure 4b. BD in the lesions of all
stages was signiﬁcantly less than that in the normal
myocardium. BD decreased with the advance from
Stage I up to Stage III. However, BD abruptly increased
in Stage IV and subsequently decreased with the
healing process of the lesion up to Stage VII.
Discussion
The present study has shown that lymphatic vessels
were not detected in stages with coagulation necrosis,
but a few lymphatics ﬁrst appeared in the peripheral
region adjacent to viable myocytes in the early
a
c
b
d
200 µm
200 µm
200 µm
2.0 mm
Figure 3. Immunohistochemistry in Stages VI (a) and VII (b–d). a, The upper half of the ﬁgure shows the lesion with ﬁbrosis (Stage VI), in which
D2-40+ lymphatics are scattered adjacent to the viable cardiomyocytes (the lower half of the ﬁgure). Their lumens are dilated. b, In Stage VII,
showing scar formation, D2-40+ lymphatics are scattered in the periphery of the lesion. c, In the scar, muscular blood vessels immunopositive
for smooth muscle actin are scattered. d, Cardiomyocytes around the scar are positive for vascular endothelial growth factor-C.
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mature granulation period and was thereafter main-
tained during scar formation. On the other hand, BD
decreased in the affected area in stages with coagula-
tion necrosis, but abruptly increased at the early stage
of granulation with subsequent decrease with the
process of MI healing. Lymphangiogenesis after the
onset of MI lagged behind blood vessel angiogenesis,
whereas VEGF-C was expressed in the cardiomyocytes
around the lesion in all stages of myocardial remodel-
ling. From these results, it can be seen that, during the
entire process of MI healing, blood vessels supply the
blood and nutrients mainly during the granulation
period, but lymphatics participate mainly in ﬁbrosis
maturation and scar formation through the drainage of
excessive proteins and ﬂuid.
In the normal heart tissue used in the present study,
D2-40+ lymphatics were abundant in the subepicardial
and subendocardial regions, as well as in the intersti-
tium around the coronary arteries and veins. These
ﬁndings are consistent with the distribution patterns
of cardiac lymphatics conﬁrmed by other methods.
3
In the light of lymphatic distribution, the abundant
lymphatics in the subepicardial region detected by
D2-40 immunohistochemistry seem to correspond to
the subepicardial lymphatic plexus, and those in the
subendocardial region to the subendocardial plexus.
3
In addition, D2-40 immunohistochemistry in this study
detected lymphatic capillaries distributing in the inter-
stitium among the cardiomyocytes, which were far
fewer in number compared with BD. Our previous
study describing lymphatic distribution in sections of
normal renal tissue, and other reports,
18,19 have also
demonstrated the usefulness of D2-40 immunohisto-
chemistry for detecting lymphatic capillaries in the
renal interstitium.
16
Myocardial necrosis after the onset of MI begins with
a wavy change of myocardial ﬁbres after a few hours,
which becomes maximal at about 5–6 days, and the
damaged myocardial ﬁbres disappear within about
2 weeks, at which stage granulation occurs.
11 In this
process of myocardial necrosis, extracellular matrices
are degraded by inﬂammatory cell proteases.
20 From
such early events after the onset of MI, it is supposed
that pre-existing vascular tissues in the affected area
also disintegrate through the inﬂuence of ischaemia
and inﬂammatory cells. The present results have
clearly demonstrated that BD in the infarcted lesion
signiﬁcantly decreases with the advance of myocardial
necrosis from Stage I up to Stage III. In Stage III, which
showed complete coagulation necrosis of myocytes
with inﬁltration of neutrophils and macrophages, blood
capillaries were not seen, whereas a few muscular
blood vessels immunopositive for SMA remained spo-
radic in the lesions. These muscular vessels should
hardly have survived because of the meagre blood
supply, as immunopositivity for CD34 was weak. On
the other hand, D2-40+ lymphatic vessels were not
detected in the affected areas in Stages II and III. The
difference of LD and BD in Stages II and III seems to be
caused by the structural difference between lymphatic
and blood vessels. Lymphatics in the cardiac intersti-
tium consist of single-layered, thin endothelial cells
which possess undeveloped basement membrane with
60
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Figure 4. Lymphatic density (LD; a) and blood vessel density (BD; b)
in the myocardium. a, LDs in the normal myocardium and the seven
categorized stages. LD means the total number of D2-40+ lymphatics
in 20 ﬁelds of view observed by light microscopy at ·200 magniﬁ-
cation. The values of LD are 21.2 ± 6.2 in the normal myocardial
tissue (Normal), 7.6 ± 4.2 in Stage I, 0 in Stage II, 0 in Stage III,
1.3 ± 1.5 in Stage IV, 22.3 ± 25.7 in Stage V, 29.7 ± 25.0 in Stage
VI and 20.8 ± 13.4 in Stage VII. There is no statistical difference
between LD values in Stages V, VI and VII. Statistical analyses were
performed by Student’s t-test. *P<0.0001; **P<0.05. b, Blood
vessel density (BD) in the normal myocardium and the seven
categorized stages. BD means the total number of CD34+ blood
vessels counted by the same methods as the value of lymphatic
density. The values of BD are 2693.4 ± 197.0 in Normal, 1689.9 ±
640.7 in Stage I, 571.4 ± 478.3 in Stage II, 51.8 ± 30.5 in Stage III,
1430.8 ± 323.1 in Stage IV, 1292.7 ± 153.1 in Stage V, 509.9 ±
276.3 in Stage VI and 130.5 ± 83.8 in Stage VII. After the onset of
myocardial infarction, the BD value decreased up to Stage III. The
BD values increased in Stage IV compared with Stage III, but
decreased with the advance of the healing process of infarcted lesion
up to Stage VII. Statistical analyses were performed by Student’s
t-test. *P<0.001; **P<0.0001.
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3 These characteristics of
lymphatic structures may cause vulnerability to ischa-
emic damage and ⁄ or degradation by proteases, as with
blood capillaries.
In the present study, BD surprisingly increased in the
early granulation phase (Stage IV), when newly formed
blood capillaries were uniformly distributed. This result
is similar to those in experimental canine MI mod-
els.
21,22 The increase in BD in the granulation phase
probably results from the effect of VEGF, because viable
cardiomyocytes around the MI lesion promptly express
VEGF after the onset of MI.
7 On the other hand, the
present study has revealed only a few lymphatics in the
peripheral region adjacent to viable cardiomyocytes
in the early granulation phase, whereas VEGF-C was
expressed in the lesion promptly after the onset of MI
and showed a signiﬁcant increase in BD in the mature
granulation phase (Stage V). In general, lymphangio-
genesis develops through budding, sprouting and ⁄ or
remodelling from the pre-existing vessels, which fre-
quently occur in pathological conditions, such as
wound healing, inﬂammation, lymphoedema and
malignant tumours.
23,24 In the process of cutaneous
wound healing in the mouse model, lymphatics appear
in subcutaneous tissue along the wound edge at 3–
5 days after injury.
25 It is therefore hypothesized that
newly formed lymphatics ﬁrst appear in the peripheral
area of the infarcted lesion through sprouting from the
pre-existing lymphatics around the lesion, and the
proliferation of lymphatics follows after blood vessel
angiogenesis.
The occurrence of lymphangiogenesis later than
blood vessel angiogenesis has been demonstrated in
excisional wound repair
26 and experimental tumours
in the mouse model,
27 as well as in the present study.
The reason why repair-associated lymphangiogenesis
occurs after blood vessel angiogenesis remains un-
known. Previous reports have disputed that a pre-
existing blood vascular bed is necessary to guide
lymphangiogenesis,
28 proposing that, on the contrary,
lymphangiogenesis can occur in the absence of a pre-
existing vascular bed.
29 A recent report has empha-
sized that the organ-speciﬁc environment is a major
determinant of lymphatic vessel formation,
26 and
another has also suggested that the delay in tumour
lymphangiogenesis compared with angiogenesis is due
to a lack of lymphatic vessels surrounding the tumour
at an early stage.
27 In the present study, VEGF-C, the
most crucial factor in the lymphangiogenic cascade,
23
was expressed in viable cardiomyocytes around the
lesion just after the onset of MI, but the increase of LD
in the lesion surprisingly lagged behind blood vessel
angiogenesis. This phenomenon is probably due to the
difference in proliferative capacity between lymphatic
and blood vessel endothelial cells or the lower density of
pre-existing lymphatics in the myocardium compared
with that of blood vessels.
In the current study, BD signiﬁcantly decreased with
healing maturation from Stage V up to Stage VII,
whereas LD showed no signiﬁcant decrease at these
stages. These results indicate that blood vessels func-
tion mainly to supply nutrients in the phase of
granulation tissue formation after myocardial necrosis,
and lymphatics participate mainly in the maturation of
ﬁbrosis and ⁄ or scar formation through the drainage of
excessive proteins and ﬂuid. In general, ﬁbrous tissue is
observed at 3 weeks after the onset of MI, with a white,
ﬁrm scar being formed by 3 months.
6,11 From these
descriptions, including our results, it is considered that
the role of lymphatics during myocardial healing may
be maintained for longer than that of blood vessels and
that immunohistochemistry using a lymphatic endo-
thelial marker is useful in investigating the role of
lymphatics in cardiac disease.
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